Showing 1 - 20 results of 53 for search 'David D Ho', query time: 0.04s Refine Results
  1. 1
    A shot in the arm for AIDS vaccine research.

    A shot in the arm for AIDS vaccine research. by David D Ho

    Published 2005-02-01
    Get full text
    Article
  2. 2
    Correction: A Shot in the Arm for AIDS Vaccine Research.

    Correction: A Shot in the Arm for AIDS Vaccine Research. by David D Ho

    Published 2005-08-01
    Get full text
    Article
  3. 3
    Engineering multi-specific antibodies against HIV-1

    Engineering multi-specific antibodies against HIV-1 by Neal N. Padte, Jian Yu, Yaoxing Huang, David D. Ho

    Published 2018-08-01
    Get full text
    Article
  4. 4
    In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies

    In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies by Chasity D. Andrews, Yaoxing Huang, David D. Ho, Rachel A. Liberatore

    Published 2020-01-01
    Get full text
    Article
  5. 5
    An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design

    An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design by Zizhang Sheng, Jude S. Bimela, Maple Wang, Zhiteng Li, Yicheng Guo, David D. Ho

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.

    Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. by Viviana Simon, Veronique Zennou, Deya Murray, Yaoxing Huang, David D Ho, Paul D Bieniasz

    Published 2005-09-01
    Get full text
    Article
  7. 7
    Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2

    Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2 by Qian Wang, Andre Yanchen Yeh, Yicheng Guo, Hiroshi Mohri, Jian Yu, David D. Ho, Lihong Liu

    Published 2023-12-01
    Get full text
    Article
  8. 8
    Quantification of SARS‐CoV‐2 viral load in patients using time‐to‐results in antigen lateral flow tests

    Quantification of SARS‐CoV‐2 viral load in patients using time‐to‐results in antigen lateral flow tests by Elsa W. Braunstein, Eric Vail, David D. Ho, Lihong Liu, Hiroshi Mohri, Matthew Gayhart, Glenn D. Braunstein

    Published 2024-02-01
    Get full text
    Article
  9. 9
    Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

    Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster by Qian Wang, Ian A. Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon, David D. Ho, Lihong Liu

    Published 2024-09-01
    Get full text
    Article
  10. 10
    A recoding method to improve the humoral immune response to an HIV DNA vaccine.

    A recoding method to improve the humoral immune response to an HIV DNA vaccine. by Yaoxing Huang, Michael Krasnitz, Raul Rabadan, Daniela M Witten, Yang Song, Arnold J Levine, David D Ho, Harlan Robins

    Published 2008-01-01
    Get full text
    Article
  11. 11
    Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern

    Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern by Qian Wang, Manoj S. Nair, Saumya Anang, Shijian Zhang, Hanh Nguyen, Yaoxing Huang, Lihong Liu, David D. Ho, Joseph G. Sodroski

    Published 2021-11-01
    Get full text
    Article
  12. 12
    Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529

    Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 by Qian Wang, Saumya Anang, Sho Iketani, Yicheng Guo, Lihong Liu, Phinikoula S. Katsamba, Lawrence Shapiro, David D. Ho, Joseph G. Sodroski

    Published 2022-06-01
    Get full text
    Article
  13. 13
    Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC

    Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC by Chandrabali Ghose, Ioannis Eugenis, Xingmin Sun, Adrianne N Edwards, Shonna M McBride, David T Pride, Ciarán P Kelly, David D Ho

    Published 2016-01-01
    Get full text
    Article
  14. 14
    2549 Characterizing the expression kinetics of HIV-1 envelope protein

    2549 Characterizing the expression kinetics of HIV-1 envelope protein by Djin-Ye Oh, Lihong Liu, Benjamin Trinité, En-Wei Hu-Van Wright, Vincent Sahi, Yaoxing Huang, David N. Levy, David D. Ho

    Published 2018-06-01
    Get full text
    Article
  15. 15
    In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections

    In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections by Chasity D. Andrews, Yang Luo, Ming Sun, Jian Yu, Arthur J. Goff, Pamela J. Glass, Neal N. Padte, Yaoxing Huang, David D. Ho

    Published 2017-12-01
    Get full text
    Article
  16. 16
    10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice

    10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice by Anastasia Lanzi, Yaoxing Huang, Jian Yu, Xin Yao, Chasity D. Andrews, Lily Tsai, Mili R. Gajjar, Michael S. Seaman, Neal N. Padte, David D. Ho

    Published 2016-05-01
    Get full text
    Article
  17. 17
    Viral kinetics of sequential SARS-CoV-2 infections

    Viral kinetics of sequential SARS-CoV-2 infections by Stephen M. Kissler, James A. Hay, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, Yonatan H. Grad

    Published 2023-10-01
    Get full text
    Article
  18. 18
    Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

    Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors by Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho

    Published 2021-04-01
    Get full text
    Article
  19. 19
    Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

    Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 by Qian Wang, Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Aubree Gordon, Lihong Liu, David D. Ho

    Published 2023-11-01
    Get full text
    Article
  20. 20
    Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

    Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors by Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho

    Published 2021-05-01
    Get full text
    Article

Search Tools: